Background and Objectives: Ovarian cancer remains the deadliest malignancy of the female reproductive system. The ability to identify and destroy all ovarian tumor nodules may have a termendous impact on preventing tumor recurrence, and patient survival. The objective of this study is to investigate the effectiveness of a nano-structured system for combined near infrared (NIR) fluorescence imaging of human epidermal growth factor receptor-2 (HER2) over-expression, as a biomarker of ovarian cancer cells, and photothermal destruction of these cells in vitro. Materials and Methods: The nano-structured system consists of the near infrared dye, indocyanine green (ICG), encapsulated within poly(allylamine) hydrochloride chains cross-linked ionically with sodium phosphate. The surface of the construct is functionalized by covalently attached polyethylene glycol, and monoclonal antibodies against HER2 using reducitve amination methods. We use dynamic light scattering, and absorption and fluorescence spectroscopy for phyiscal characterization of the constructs. Flow cytometry and fluorescence microscopy are used to investigate molecular targeting and imaging capabilities of the constructs against SKOV3 and OVCAR3 ovarian cancer cell lines, which have relatively high and low expression levels of the HER2 receptor, respectively. Continuous NIR laser irradiation at 808 nm is used to investigating the utility of the constructs in mediating photothermal destruction of SKOV3 cells. Results: Flow cytometry results indicate that the functionalized nano-constructs are more effective in targeting the HER2 receptor than non-encapsulated ICG and non-functionlaized constructs (P < 0.005). Fluorescence microscopic images show the capaiblity of the functionalized constructs in NIR imaging of HER2 overexpression. The functionalized nano-constructs are also capable of inducing a significantly greater increase in photothermal destruction of SKOV3 cells than free ICG and non-functionalized constructs (P < 0.005). Conclusion: We have demonstrated the efficacy of polymeric nano-structured constructs loaded with ICG, and functionalized with the monoclonal antibodies, as thernaostic materials for targted molecular NIR imaging of the HER2 receptor overexpression on ovarian cancer cells, and photothermal destruction of these cells. These nanoparticles may prove useful towards intraoperative detection, imaging, and phototherapy of small ovarian cancer nodules.
INTRODUCTION
Ovarian cancer is the deadliest gynecological cancer in women [1] . Only about 20% of ovarian cancers are diagnosed when the disease is confined to the ovaries [2] (classified as stage I [3] ). Once the disease spreads beyond the ovaries, and extends into the pelvis (below the pelvic brim) (stage II), the peritoneum outside the pelvis and/or into the retroperitoneal lymph nodes (stage III), or metastasizes distantly to hepatic and/or splenic parenchymal or the extra-abdominal organs (stage IV), the survival rate is greatly diminished [2] , with 5-year survival rates less than 20% [4] .
Treatment of ovarian cancer is based on cytoreductive surgery, with the goal of reducing the burden of the cancer to none or minimal residual tumor deposits, followed commonly by administration of standard chemotherapeutic combination of carboplatin and paclitaxel [5] [6] [7] . However, most patients suffer from recurrence, and are chemoresistant [5, 7] .
The degree of success in cytoreductive surgery is an important prognostic factor, with improved survival associated with complete resection of all visible cancer [8] [9] [10] . Yet, a great challenge during cytoreduction remains the detection of small (diameter <1 cm) intraperitoneal tumor deposits. The current surgical standard is to remove all visible deposits, on the order of 1-2 cm nodules. Smaller nodules are difficult to detect pre-operatively by computed tomography scans, magnetic resonance imaging, or visually at surgery, and if left behind, can result in recurrence, which is unfortunately all too common with this disease. It is both widely metastatic disease that cannot be removed at the time of surgery and the chemoresistance of ovarian cancer that results in high mortality from ovarian cancer.
Imaging methods that can identify small tumor nodules, not detectable by existing methods, offer the potential to enhance diagnosis and lead to improved therapeutic outcomes. Intraoperative fluorescence imaging based on materials that are optically activated by near infrared [NIR] wavelengths [%700-1,450 nm] provides a potentially effective approach. NIR imaging provides two key advantages: (1) due to the reduced absorption of photons by water and proteins, as well as the diminished scattering within the NIR spectral band, optical penetration depth is increased to allow identification of tumors extending to %2-3 cm in depth; and (2) given that there is minimal autofluorescence in the NIR spectral bands, the use of an exogenous chromophore enhances the imaging contrast. Intraoperative NIR fluorescence imaging, as an optical modality with high resolution (%100 mm), has gained entry into early clinical studies [11, 12] . By combineing it with a molecular targeting agent, the specificity of such fluorescent probes can be enhanced.
One particular NIR imaging agent is indocyanine green [ICG] . The first medical applications of ICG date back to the late 1950s for measurements of cardiac output. The finding that ICG is almost exclusively taken up by the liver, led to its application in assessment of hepatic function. In 1975, ICG received supplemental approval by FDA for ophthalmic angiography. To-date, ICG remains the only FDA-approved NIR dye for cardiocirculatory measurements, liver function tests, and imaging of selective ophthalmological disorders including suspected polypoidal choroidal neovascularization, chronic central serous chorioretinopathy, and choroidal hemangioma. ICG has also been investigated for sentinel lymph node (SLN) mapping and staging in cancer patients [13] [14] [15] [16] . In addition to its NIR imaging capabilities, ICG has been studied for potential phototherapeutic applications including treatment of chronic central serous chorioretinopathy [17] , and cutaneous hypervascular malformations [18, 19] .
Despite its usage in clinical medicine, the major drawbacks of ICG are its short half-life within plasma [%2-4 minutes], and lack of targeting capability. ICG encapsulation has been investigated as a methodology to overcome these limitations [20, 21] . We have reported that encapsulation of ICG into nanocapsules composed of the polymer poly(allylamine) hydrochloride (PAH) chains cross-linked ionically with sodium phosphate, and coated with polyethylene glycol (PEG), delays maximal hepatic accumulation to at least 60 minutes after tail vein injection in mice [22] . Furthermore, the reactive amines on the encapsulating shell provide a platform to attach appropriate moieties for targeted molecular imaging of a disease biomarker.
The human epidermal growth factor receptor-2 (HER2), presents an important biomarker for targeted imaging of ovarian cancer cells. HER2 is one of the four members of the HER family of transmembrane proteins (HER1, HER2, HER3, and HER4), all of which play a key role in carcinogenesis of various solid tumors, particularly breast, colorectal, non-small cell lung cancer, and ovarian cancer [23] [24] [25] . Among the four family proteins, HER2 has the strongest catalytic kinase activity, and its aberrations (gene amplification, gene mutations, and protein overexpression) are reported in diverse malignancies, including ovarian cancer [26] . The reported percentage of ovarian cancer patients with HER2 overexpression is variable, and ranges between approximately 5-52% [27] [28] [29] [30] [31] . According to a recent study, conventional immunohistochemical (IHC) analysis underestimates the true frequency of HER2 expressing ovarian cancers [32] . Whereas IHC analysis revealed HER2 overexpression in only 29% of high-grade ovarian serous carcinoma sites, more sensitive detection methods including flow cytometry, Western blot analysis, and quantitative-polymerase chain reaction (q-PCR) demonstrated HER2 expression in all tumor cells derived from solid tumors and primary ascites, as well as all established and short-term cultured cancer cells [32] . Importantly, HER2 overexpression is reported to have prognostic significance since increased HER2 expression has been correlated with reduced survival [31] , and increased risk of progression and death [29, 30] .
Our nano-construct system composed of ICG-doped nanocapsules (ICG-NCs), functionalized with an antagonist against the HER2 receptor, offers a potential platform for targeted molecular imaging of an important biomarker associated with ovarian cancer. Moreover, the encapsulated ICG can potentially serve as a therapeutic agent to induce photothermal destruction of the cancer cells in response to NIR laser irradiation. Therefore, detection, imaging, and phototherapeutic capabilities can be provided by a single nano-structured NIR platform. Herein, we report the effectiveness of these nano-constructs for targeted NIR fluorescence imaging of ovarian cancer cells expressing HER2 receptors, and photothermal destruction of these cells in vitro. [33] , and has relatively high expression levels of the HER2 receptor [34] . As control cells, we used the OVCAR3 cell lines (ATCC 1 ), established from the malignant ascites of human ovarian adenocarcinoma, which have relatively low expressions of the HER2 receptor [35] . Cells were cultured separately in McCoy's 5a Medium supplemented with 10% fetal bovine serum, and 1% penicillin.
MATERIALS AND METHODS

Reagents
ICG-NCs Synthesis and Antibody Conjugation
We have previously reported the fabrication process of ICG-NCs in details [22, 36, 37] . Briefly, 10 ml of disodium hydrogen phosphate heptahydrate solution (0.01 M, 48C) and 20 ml of PAH stock solution (2 mg/ml, 48C) were mixed in the first step. The resulting nanoparticle suspension was diluted by adding 1.2 ml pre-cooled deionized water (48C) immediately before addition of 240 ml of ICG aqueous solution (0.65 mM, 48C). The ICG-NC suspension was aged for 15 minutes at 48C followed by washing through differential centrifugation described in details previously [22] .
To covalently attach the anti-HER2 antibodies to the surface of the nano-constructs, we utilized our previously reported biochemical methods based on reductive amination ( Fig. 1) [37, 38] . Specifically, we added single-aldehyde terminated 5 kDa polyethylene glycol (PEG) and doublealdehyde terminated 10 kDa PEG polymers, in an equal ratio, to 1 ml of the ICG-NCs solution, followed by addition of 200 ng of anti-HER2. The double aldehyde-terminated PEG serves as the linker for covalent attachment to the available amines on the surface of ICG-NCs, and the amines on the antibody. The single aldehyde-terminated PEG serves to reduce non-specific protein adsorption to the surface of ICG-NCs [37] . A previous study has demonstrated that among PEG molecules with molecular weight in the range of 1-20 kDa, the use of the 5 kDa PEG provided the optimal covalently grafted coating to suppress non-specific adhesion [39] .
We subsequently added 5 ml of 0.02 M sodium dithionite as the reducing agent. The suspension was gently mixed for 10 seconds and aged for 1 hour at 48C in the dark, and then washed by centrifugation twice at 4,600g for 10 minutes. The pelleted ICG-NCs coated with anti-HER2 and PEGylated (referred to as anti-HER2-PEG-ICG-NCs) were resuspended in PBS and stored at 48C in dark.
Characterization of Functionalized ICG-NCs
The hydrodynamic diameter of non-functionalized ICGNCs and anti-HER2-PEG-ICG-NCs were measured by dynamic light scattering (DLS) (Zetasizer Nanoseries, NanoZS90, Malvern Instruments, Malvern, UK). The absorption spectra of non-functionalized ICG-NCs and anti-HER2-PEG-ICG-NCs were obtained using a UVVisible spectrophotometer (Cary 50 UV-Vis spectrophotometer, Agilent Technologies, Santa Clara, CA) with optical pathlength of 1 cm. The fluorescence spectra of ICGNCs, in response to 680 nm excitation with a 450 W xenon lamp, were recorded using a fluorometer (Fluorolog-3 spectrofluorometer, Edison, NJ). We obtained the normalized fluorescence spectra z(l) as:
where F(l) is the recorded emission intensity at wavelength, l, and A(l ex ) is the absorbance value of the sample at excitation wavelength, l ex .
Flow Cytometry
A flow cytometer (FACSAria cell sorter, BD Biosciences, San Jose, CA) was used to quantify the specific targeting of the SKOV3 cells with anti-HER2-PEG-ICG-NCs. SKOV3 cells were cultured in 12 wells plates a night before the experiments. On the following day, the SKOV3 cells were incubated in the dark at 378C with either free ICG, nonfunctionalized ICG-NCs, or anti-HER2-PEG-ICG-NCs for various time intervals ranging between 30 minutes and 3 hours, and supplied with 5% CO 2 . SKOV3 cells not incubated with any of the agents were used as a negative control. Following each incubation time, cells were washed with PBS twice through centrifugation (135g for 4 minutes) and re-suspended in PBS. Dead cells were identified by the Propidium iodide (PI) assay, and excluded from the analysis. The prepared samples were excited at 633 nm, with emission collected at >785 nm. We define the percentage of ICG positive SKOV3 cells as the ratio of those cells emitting NIR signal to the total number of live cells.
Fluorescence Microscopy
To prepare the samples for fluorescence microscopy, 100 ml of SKOV3 or OVCAR3 cell suspension in fresh media (%10 6 cells/ml) was added to each well of a 96-well flatbottomed micro-titer plate. In the first set of experiments, we intentionally incubated the cells at 48C with either free ICG, non-functionalized ICG-NCs, or anti-HER2-PEG-ICG-NCs to minimize/prevent internalization of the constructs, which normally occurs at 378C. Cell suspensions were plated in 5% CO 2 overnight. On the following day, the old culture medium was replaced with fresh medium, and 100 ml of free ICG (10 mM, dissolved in PBS), non-functionalized ICG-NCs, or anti-HER2-PEG-ICGNCs was added to different wells. All three agents had the same absorbance value (%0.75) at 680 nm. Cells were incubated with the agents for 3 hours at 48C in the dark, and subsequently washed twice with cold PBS. Finally, we incubated the cells with 4 0 ,6-diamidino-2-phenylindole (DAPI) for 10 minutes to stain cell nuclei for fluorescence imaging. The fluorescence emission from DAPI in the range of 435-485 nm was collected in response to 360 AE 20 nm excitation by a Nikon Mercury/Xenon arc lamp. The NIR fluorescence emission (>770 nm) in response to 740 AE 35 nm excitation was captured using a long pass filter in conjunction with an electron multiplier CCD camera (Quant EM-CCD, C9100-14, Hamamatsu, Shizuoka-ken, Japan) with 100 milliseconds integration time.
In the second set of experiments, we evaluated the interaction of the SKOV3 cells with free ICG, nonfunctionalized ICG-NCs, or anti-HER2-PEG-ICG-NCs at physiological temperature (378C). The procedure was identical to that used for 48C incubation except that the incubation time at 378C for the various agents was 2 hours. SKOV cells incubated at 378C were fluorescently imaged using a confocal microscope (Pathway High Throughput Automated Imager, Atto Biosciences, Rockville, MD). The cells nuclei, labeled with DAPI, were imaged using an excitation wavelength of 350 nm excitation wavelength with fluorescence emission > 400 nm captured by a long pass filter. NIR fluorescence images were acquired for emissions >780 nm in response to 780 nm excitation. The camera exposure time was set at 1 second. We present all microscopic fluorescent images as the overlay of the NIR emission due to ICG (red channel), and visible emission due to DAPI-stained nuclei (blue channel).
Laser Irradiation
To quantify the photothermal response of anti-HER2-PEG-ICG-NCs to NIR irradiation, we irradiated 120 ml of functionalized ICG-NCs suspended in PBS at 808 nm. For comparison, we irradiated 120 ml of 17.2 mM free ICG dissolved in PBS, and non-functionalized ICG-NCs suspended in PBS. In this manner, the three agents had the same absorbance value (%0.8) at 808 nm. We irradiated 120 ml of PBS as the negative control. For all samples, the irradiated spot diameter (d o ), irradiance (I o ), and irradiation time (Dt laser ) were 2.2 mm, 19.7 W/cm 2 , and 180 seconds, respectively. Temperature during irradiation of each sample was measured using a negative temperature coefficient thermistor (20 kV, Vernier), placed 2 mm outside the irradiation spot, and connected to a Vernier LabQuest.
To investigate the photo-destructive capability of anti-HER2-PEG-ICG-NCs, we cultured SKOV3 cells in 96-wellplates over night to yield cell density of %10 6 cells/ml. On the following day, cells were incubated with either 17.2 mM free ICG dissolved in PBS, non-functionalized ICG-NCs, or anti-HER2-PEG-ICG-NCs (latter two suspended in PBS) in separate wells for 3 hours in dark at 378C supplied with 5% CO 2 . When applied at the volume of 12.5 ml, all three agents had the same absorbance value (%0.8) at 808 nm. We also performed experiments where we added increasing volumes (25, 50, 100, and 200 ml) of the solution of each agent to the cells. In the case of free ICG, effectively larger amounts of ICG were applied with increased volumes since we maintained the same ICG concentration (17.2 mM) in all volumes. We expect that in the cases of ICG-NCs and anti-HER2-PEG-ICG-NCs, increasing the applied volume from 12.5 to 200 ml effectively increased the number of particles by %16 times. Cells were then washed twice with PBS prior to laser irradiation experiments. SKOV3 cells incubated with PBS were irradiated as negative control. Each well was irradiated at two different spots (d o ¼ 2.2 mm) using an 808 nm laser wavelength with Dt laser ¼ 200 seconds, and
Following laser irradiation, cells were stored for 2 hours at 378C supplied with 5% CO 2 . Cell viability in each well was analyzed using a live/dead assessment kit for mammalian cells (L3224, Invitrogen, Carlsbad, CA) and a fluorescent microplate reader (Molecular Devices FlexStation II 384, Harlow Scientific, Arlington, MA). Specifically, live cells were identified using Calcein (l excitation ¼ 494 nm, peak l emission ¼ 517 nm), and dead cells by Ethidium homodimer-1 (l excitation ¼ 528 nm and peak l emission ¼ 617 nm) staining.
RESULTS
The estimated peak diameter of non-functionalized ICGNCs and anti-HER2-PEG-ICG-NCs were 58 and 102 nm, respectively ( Fig. 2A) . Thus, the thickness of the coating composed of mixed 5 kDa PEGs, and 10 kDa PEGs as linkers for attachment of anti-HER2, was about 22 nm. The absorption spectrum of anti-HER2-PEG-ICG-NCs suspended in PBS was nearly identical to that of nonfunctionalized ICG except in the range <309 nm (Fig. 2B) , indicating the successful grafting of the antibodies to the surface of the nano-constructs. The anti-HER2-PEG-ICGNCs also retained their fluorescence capability (Fig. 2C) .
As determined by flow cytometry, the population distributions of SKOV3 cells incubated with anti-HER2-PEG-ICG-NCs demonstrated a shift to the right (higher ICG fluorescent signal) as incubation time increased from 30 minutes to 3 hours at 378C (Fig. 3A-D) . Moreover, at all incubation times, notably larger population of SKOV3 cells were detected in ICG fluorescent channel. The population distributions of SKOV3 cells incubated with free ICG and non-functionalized ICG-NCs, detected in ICG channel, were very close to the negative control (SKOV3 cells incubated only in culture medium without any NIR reagents) at 30 minutes and 1-hour post-incubation. The number of cells detected in ICG channel increased for 2 and 3 hours of incubation times with nonfunctionalized ICG-NCs, but still remained low for cells incubated with free ICG.
The fraction of ICG positive SKOV3 cells was significantly higher for those incubated with anti-HER2-PEG-ICG-NCs, and became progressively larger with increased incubation time (Fig. 3E) . For example, at 3 hours of incubation time, approximately 76% of the SKOV cells incubated with anti-HER2-PEG-ICG-NCs were ICG positive, nearly four times higher than those cells incubated with non-functionalized ICG-NCs. The highly specific molecular targeting of the HER2 receptor was further validated by fluorescence imaging of cells incubated with anti-HER2-PEG-ICG-NCs at 48C for 3 hours (Fig. 4) . The overlay of the NIR and visible fluorescent images of the SKOV3 cells incubated with anti-HER2-PEG-ICG-NCs showed the localization of the functionalized particles on the SKOV3 cell membrane as the red ring. The OVCAR3 cells, and SKOV3 cells incubated with free ICG or non-functionalized ICG showed none or minimal NIR signal. These results suggest that the interaction of anti-HER2-PEG-ICG-NCs with SKOV3 cells was highly specific and receptor-mediated.
We present confocal fluorescent images of SKOV3 cells after 2 hours of incubation with freely dissolved ICG, nonfunctionalized ICG-NCs, and anti-HER2-PEG-ICG-NCs at physiological temperature (378C) (Fig. 5) . NIR emission was detected from SKOV3 cells incubated with anti-HER2-PEG-ICG-NCs, and the constructs appeared to be localized to the peripheries of the cell nuclei. There was no or minimal NIR emission from the SKOV3 cells incubated with freely dissolved ICG, or non-functionalized ICG-NCs. These results confirm that specific targeting of SKOV3 cells at physiological temperatures can be achieved by anti-HER2-PEG-ICG-NCs.
The photothermal responses of ICG-NCs with and without surface functionalization were similar to that of free ICG under the same irradiation conditions (Fig. 6A) , indicating that encapsulation did not compromise the heat generating capability of ICG.
Respective temperature rises to maximum values of %50, 52, and 528C, from the baseline temperature of 208C, during the first 100 seconds of irradiation of free ICG, nonfunctionalized ICG-NCs, and anti-HER2-PEG-ICG-NCs, were followed by reductions in temperature. These temperature measurements represent the lower bound estimates of the actual temperature rises of the three agents since they were made at a distance of 2 mm away from the irradiated spot. We attribute the reduction in temperature with sustained laser irradiation to thermallyinduced degradation in optical absorption properties of ICG [40] .
The 2 ) fractions of SKOV3 cell death were significantly greater (P < 0.005) with HER2-PEG-ICGNCs than those induced by free ICG, or non-functionalized ICG-NCs at all investigated volume levels (Fig. 6B) , indicating that anti-HER2-PEG-ICG-NCs were effective in photothermal destruction of SKOV3 cells. For example, when applied at 200 ml, anti-HER2-PEG-ICG-NCs were able to induce nearly 86% cell death.
DISCUSSION
We have previously demonstrated the utility of nonfunctionalized IC-NCs for in vivo NIR fluorescence imaging in healthy mice [22, 41] , and investigated their heat generation capability in tumor-simulating phantoms [42] . We have also determined that only about 5% of ICG is released from the capsules after 1 hour of incubating the constructs in Dulbecco's Modified Eagle Medium supplemented with 10% fetal bovine serum at 378C, with the released fraction approaching a steady value of %8% after 24 hours [43] . The present study is the first demonstration of the use of these constructs, conjugated at their surface with covalent attachment of PEG and anti-HER2, and using ICG as the single chromophore for both NIR fluorescence imaging and photothermal destruction of ovarian cancer cells.
The estimated coating thickness on the surface of the constructs is about 22 nm. Upadhyayula et al. [39] have measured the average thickness of PEG layers with molecular weights, in the range of 1-20 kDa, grafted on flat surfaces using spectroscopic elipsometry. They . Two different spots were irradiated in each sample. Cells were incubated with five different volumes of free ICG (17.2 mM), nonfunctionalized ICG-NCs, or anti-HER2-ICG-NCs functionalized ICG-NCs for 3 hours. SKOV3 cells incubated with PBS were used as negative control. Bars represent mean of three different samples, and error bars are the standard deviations. Asterisks denote statistically significant differences in cell death between those incubated with anti-HER2-PEG-ICG-NCs at a given volume, and those incubated with the other agents at the corresponding volume (P < 0.005, two-tailed t-test).
estimated the thicknesses of the 5 and 10 kDa PEG layers as 23 and 33 nm, respectively. The coating of the NCs appears to be closer to the 5 kDa, which we can attribute to several factors: (1) the 5 kDa PEG chains dominate the packing while the 10 kDa PEGs could be bent and even loop to bind to the particles via their two termini; (2) compared to flat surfaces, the large curvature of the NCs may contribute to decrease in the thickness of the coating because of a decrease in the packing density toward the exterior of the layer; and (3) the antibody, that has dimensions in the order of 10 nm in length does not contribute to the effective thickness of the coating as measured by DLS.
We attribute the absorption peak of the anti-HER2-PEG-ICG-NCs at 270 nm (Fig. 2B) to electronic transitions in amino acids such as tryptophan and tyrosine associated with the antibody. The NIR absorption band in 730-810 spectral range is attributed to the ICG. In comparison to free ICG dissolved in PBS at diluted concentrations (e.g., %3 mM), which has a distinct spectral peak at 780 nm (associated with monomeric form of ICG [40] ), ICG-NCs have nearly uniform absorbance values in the 730-810 nm spectral range. This near uniform absorption over the 730-810 nm is consistent with our previously reported spectra for non-functionalized ICG-NCs [36, 37] , and can be attributed to the presence of various conformational states of ICG when encapsulated, including ICG bound to PAH. In response to photo-excitation at 680 nm, these constructs exhibit NIR emissions peaks at 792 and 700 nm, which can originate from the monomer and H-like aggregate forms of ICG, respectively [44] .
The effectiviness of using the non-NIR fluorescent tracer, fluorescein isothiocyanate [FITC] (with peak emission at 520 nm when photo-excited at 495 nm), conjugated with folate hapten for targeted real time optical imaging of the folate receptor-a overexpression as a biomarker, was demonstrated for the first time in women with ovarian cancer [45] . Disseminated tumor deposits within the peritonum could be visualized with resolution of %1 mm. Despite the use of non-NIR wavelengths, this study clearly demonstrated that molecularly-targeted intraoperative fluorescence imaging of intraperitoneal tumors in humans is feasible, and provides a potentially effective approach for detection of disseminated noduldes that cannot be currently identified by existing methods.
There have been several recent studies in using NIR exogenous chromophores without and with targeting moieties for fluorescent imaging of peritoneal ovarian tumors in mice [33, [46] [47] [48] [49] . While some of these studies report the feasibility of imaging sub-millimeter tumor nodules [46, 47, 50] , combined NIR imaging and photothermal destruction of ovarian tumors were not investigated. In one study, xenografted tumor nodules as small as %300 mm could be imaged in mice peritoneal cavity at 6 and 24 hours post-administration of 100 ml of 100 mM free ICG dissolved in PBS via the tail vain [50] . Since no specific molecular biomarker were targeted in this study, the accumulation of free ICG in tumors may have been due to the enhanced permeability and retention effect [51, 52] , where ICG may resemble a macromolecule upon binding to serum proteins such as albumin [50] .
On the phototherapeutic side, there is precedence for photodynamic therapy (PDT) of intraperitoneal tumors in humans as a non-photothermal approach that relies mainly on formation of singlet oxygen or radicals as cytotoxic agents [53] [54] [55] . In one study [54] , 13 ovarian cancer patients underwent PDT using the chromophore dihematoporphyrin ethers (DHE), in conjunction with 630 nm laser irradiation, where light was delivered to mesentery and bowel by a flat-cut optical fiber. In other areas, including the pelvis, light was delivered through a diffusing wand. In another study [55] , 39 patients underwent debulking surgery and PDT using DHE in conjunction with either 630 or 514 nm laser irradiation. In some patients, the entire peritoneal surface was laser irradiated. Therefore, intraoperative laser irradiation of intraperitoneal tumors in humans is also possible. Nevertheless, these studies lacked specific tumor targeting and imaging capabilities to determine the spatiotemporal distribution of the chromophore in tumors. Our results presented herein indicate that anti-HER2-PEG-ICG-NCs provide capabilities for biomarker detection, imaging, and photothermal theraphy in a single nano-structured NIR optical platform.
In a recent in vitro study, Mir et al. [56] demonstrated the effecacy of photo-destruction of OVCAR5 human epithelial ovarian carcinoma cells using a pre-formed commerically aviablable liposomal system. Benzoporphyrin derivative monoacid A as the PDT agent, and Cetuximab (C225) to target HER1, were passively (noncovalently) adsorbed on the surface of the liposomes [56] . The investigators showed that the combined use of PDT and C225 to inhibit HER1 activity was more effective in cell killing as compared to either PDT or C225 application alone. In comparison to our study where ICG is used as both the imaging and therapeutic agent, a second chromophore, FITC, was used to lable the C225 and quantify the cellular uptake of the construct.
The combined effects of doxorubicin (DOX), an anthracycline antibiotic chemotherapeutic agent, and ICGmediated hyperthermia on SKOV3 cells have been investigated in vitro [57] . Hyperthermia, mediated by use of 5 mM free ICG, in combination with DOX achieved significantly greater cell death than DOX alone, indicating the added benefit of heating in destruction of the ovarian cancer cells. Nevertheless, ICG as applied in that study, did not have specific targeting capability, and thermal injury was likely induced by heat diffusion resulting from laser-irradiated ICG in solution as opposed to direct heating of the cells uptaking ICG.
Chen et al. [58] have demonstrated the utility of nanocomplexes consisting of a silica core surrounded by a gold nanoshell, further doped with ICG and superparamagnetic iron oxide, for dual NIR and MRI, and photothermal destruction of OVCAR3 cells in vitro. The surface of the nano-complex was modified by attachment of streptavadin, which served as the binding site for biotinylated anti-HER2 rabbit antibody. In contrast to these nano-complexes, ICG-NCs provide several key advantages: (1) the nanocapsules spontaneously selfassemble by electrostatically-driven cross-linking of PAH polymer with phosphate anions; (2) fabrication process is entirely based on green chemistry in aqueous media within 10-30 seconds, with entire time to dope the nanocapsules with ICG not exceeding 3 hours; and (3) the inherent presence of the amines on the surface of capsules provide addressable sites for covalent attachment of various targeting moieties including the anti-HER2 antibody, without the need for additional attachment of other molecules such as streptavadin. While this proof-ofconcept study has been limited to target cells that overexpress HER2, ICG-NCs can be functionalized with other moieties to target other potential biomarkers such as the folate receptor-a, or possibly be tailored to a patient specific biomarker.
Our results demonstrate that the percentage of cell death in vitro is directly proportional to the volume of the PBS solution containing the anti-HER2-PEG-ICG-NCs, or effectively the number of these nanoparticles (Fig. 6B) . Whereas nearly 86% cell death occurred in response to application of 200 ml of solution, it is quite reasonable to expect that the in vitro percentage of cell death can increase further and approach 100% by increasing the solution volume (number of particles). Secondly, the percentages of cell death in this study were in response to I o value of 19.7 W/cm 2 . Increased levels of I o should results in greater percentage of cell death in vitro. Therefore, by optimal combinations of solution volume (number of particles) and I o , 100% cell death can possibly be achieved in vitro. Thirdly, two spots were irradiated in each well, leaving those cells close to the wall of the wells non-irradiated. In view of using non-optimal solution volume (particles number) and I o , and despite not capturing all the cells in the wells for irradiation, we were still able to achieve 86% cell death in vitro by using anti-HER2-PEG-ICG-NCs.
While in this study, photothermal destruction of SKOV3 cells was achieved by inducing temperature elevations above 508C, it may also be possible to induce cell death by laser-induced hyperthermic effects involving lower temperature increases maintained over longer irradiation times. For example, it has been indicated that almost 100% of colon adenocarcinoma cell lines could be destroyed when they were maintained at temperature of 458C for about 40 minutes [59] . Our future work will include studies aimed at investigating the effectiveness of anti-HER2-PEG-ICG-NCs as theranostic agents for fluorescence imaging and photothermal destruction of ovarian tumors in animal models, and optimizing the laser irradiation parameters and the number of anti-HER2-PEG-ICG-NCs.
CONCLUSION
We have carried out an in vitro study that demonstrates the effectiveness of an optical nano-platform, consisting of the NIR chromophore ICG encapsulated within a polymerbased structure with covalently attached antibodies at the surface, for targeted molecular fluorescence imaging of the HER2 receptor as an ovarian cancer biomarker, and photothermal destruction of ovarian cancer cells expressing this biomarker. These constructs may provide the capability for intraoperative detection, imaging, and phototherapy of small ovarian cancer nodules in conjunction with open surgical procedures associated with clinical management of ovarian cancer.
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